Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's What Investors Need to Know About Johnson & Johnson's Split


Last month, pharmaceutical giant Johnson & Johnson (NYSE: JNJ) announced a change that investors never saw coming. The company plans to split its pharmaceutical and medical device business from its legacy consumer health business. Fool contributors Rachel Warren and Toby Bordelon discuss the terms of the split in this segment of Backstage Pass, recorded on Nov. 19

Continue reading


Source Fool.com

Like: 0
JNJ
Share

Comments